Efficacy of concurrent chemoradiotherapy with thalidomide and S-1 for esophageal carcinoma and its influence on serum tumor markers

Figure 3 Quality of life of esophageal cancer patients. A: The research group had markedly higher physical function scores than the control group after treatment; B: The research group had markedly higher role function scores than the control group after treatment; C: The research group had statistically higher emotional function scores than the control group after treatment; D: The research group had markedly higher social function scores than the control group after treatment; E: The research group had obviously higher cognitive function scores than the control group after treatment. ^bP < 0.01, vs before treatment.